Veracyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.

CEO

Marc A. Stapley

CEOMarc A. Stapley

Employees

824

Employees824

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2006

Founded2006

Employees

824

Employees824

VCYT Key Statistics

Market cap

2.44B

Market cap2.44B

Price-Earnings ratio

102.56

Price-Earnings ratio102.56

Dividend yield

—

Dividend yield—

Average volume

769.87K

Average volume769.87K

High today

$31.76

High today$31.76

Low today

$31.11

Low today$31.11

Open price

$31.60

Open price$31.60

Volume

137.12K

Volume137.12K

52 Week high

$47.32

52 Week high$47.32

52 Week low

$19.48

52 Week low$19.48

VCYT News

TipRanks 4d

Veracyte expands Decipher Prostate test availability

Veracyte (VCYT) announced the launch of its Decipher Prostate Metastatic Genomic Classifier for use in patients whose prostate cancer has spread beyond the prim...

Analyst ratings

77%

of 13 ratings

Buy

76.9%

Hold

15.4%

Sell

7.7%